Anticancer effects of metformin in experimental animal models of different types of cancer: a systematic review and meta-analysis
Authors:
Open Access
- 19 July 2022
- journal article
- review article
- Published by Springer Nature in Laboratory Animal Research
- Vol. 38 (1) , 1-8
Abstract
To systematically evaluate the effects of metformin on tumors in experimental animal models of different types of cancer. Pubmed, Embase, Cochrane, and Web of Science databases were searched for studies on metformin used in various experimental animal tumor models from 2008 to 2022. Meta-analysis was performed using STATA 16.0 software after screening literature extraction data and methodological quality evaluation by inclusion and exclusion criteria. A total of 24 studies with 1108 model animals were included. Meta-analysis results showed that this study used meta-analysis for quantitative synthesis of study results and found that tumor model animals of different species showed different degrees of reduction in tumor volume, weight, and number after metformin intervention.Keywords
Funding Information
- Tianjin Municipal Education Commission Scientific Research Program Project (2020KJ143)
This publication has 24 references indexed in Scilit:
- Metformin Suppresses Pancreatic Tumor Growth With Inhibition of NFκB/STAT3 Inflammatory SignalingPancreas, 2015
- Metformin inhibits ovarian cancer growth and increases sensitivity to paclitaxel in mouse modelsAmerican Journal of Obstetrics and Gynecology, 2015
- Metformin and Rapamycin Reduce Pancreatic Cancer Growth in Obese Prediabetic Mice by Distinct MicroRNA-Regulated MechanismsDiabetes, 2015
- Combination of Metformin and Statins Significantly Enhanced the Local Radio therapeutic Effect and Attenuated the Lung Metastasis of Lewis Lung Carcinoma (LLC) Animal ModelInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2014
- Metformin Inhibits Hepatocellular Carcinoma in a Cirrhosis ModelJournal of Surgical Research, 2014
- Colon epithelial proliferation and carcinogenesis in diet‐induced obesityJournal of Gastroenterology and Hepatology, 2013
- S2011 Metformin Inhibits the Growth of Human Pancreatic Cancer Cells In Vitro and In VivoGastroenterology, 2009
- Metformin, Sulfonylureas, or Other Antidiabetes Drugs and the Risk of Lactic Acidosis or HypoglycemiaDiabetes Care, 2008
- Metformin attenuates the stimulatory effect of a high-energy diet on in vivo LLC1 carcinoma growthEndocrine-Related Cancer, 2008
- Pooling of Animal Experimental Data Reveals Influence of Study Design and Publication BiasStroke, 2004